Endurant Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Endurant Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,815	Closed	-$643K	–	72
2019 Q3	$643K	Sell	37,815 -232,746	-86%	-$4.24M	0.23%	45
2019 Q2	$6.16M	Buy	270,561 +205,004	+313%	+$5.53M	2.43%	20
2019 Q1	$2.11M	Buy	+65,557	New	+$2.03M	0.83%	36
2016 Q2	–	Sell	-12,000	Closed	-$228K	–	96
2016 Q1	$228K	Sell	12,000 -28,000	-70%	-$507K	0.07%	84
2015 Q4	$900K	Buy	+40,000	New	+$791K	0.3%	59
2015 Q3	–	Sell	-17,135	Closed	-$491K	–	98
2015 Q2	$491K	Sell	17,135 -45,865	-73%	-$1.2M	0.14%	86
2015 Q1	$1.63M	Buy	+63,000	New	+$1.44M	0.54%	58

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Endurant Capital Management's XENT Position: Q4 2019 in Review

Endurant Capital Management sold out of Intersect ENT, Inc (XENT) in Q4 2019, closing a stake of 37,815 shares — an estimated $643K sold.

Endurant Capital Management first reported a position in XENT in Q1 2015 and held it in 7 quarters. The position peaked at $6.16M in Q2 2019. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

Endurant Capital Management reported no remaining Intersect ENT, Inc position as of Q4 2019 after selling out during the quarter.
Endurant Capital Management sold 37,815 Intersect ENT, Inc shares in Q4 2019, an estimated $643K.
Endurant Capital Management first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 7 quarters.
Endurant Capital Management's Intersect ENT, Inc position peaked at $6.16M in Q2 2019.
120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Endurant Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.